Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Oldenburg

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Pharmacogenetics and Genomics|September 11, 2009
Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histologySigrid M Kraggerud, Jan Oldenburg, Grethe I Alnaes, et al.
Journal of Cancer Survivorship : Research and Practice|February 28, 2016
Aspects of posttraumatic stress disorder in long-term testicular cancer survivors: cross-sectional and longitudinal findingsAlv A Dahl, Marie Østby-Deglum, Jan Oldenburg, et al.
European Urology|September 4, 2012
Contemporary management of postchemotherapy testis cancerSiamak Daneshmand, Peter Albers, Sophie Dorothea Fosså, et al.
BMC Molecular and Cell Biology|June 3, 2021
Methodology for comprehensive cell-level analysis of wound healing experiments using deep learning in MATLABJan Oldenburg, Lisa Maletzki, Anne Strohbach, et al.
Oncotargets and Therapy|February 2, 2017
Overall survival in renal cell carcinoma after introduction of targeted therapies: a Norwegian population-based studyChristian Beisland, Tom B Johannesen, Olbjorn Klepp, et al.
Cancer Management and Research|January 28, 2025
Overall Survival of Patients with Metastatic Renal Cell Carcinoma Following the Introduction of Targeted and Immunotherapies: A Norwegian Retrospective, Real-World Registry Data Study (RECON3)Katarina Puco, Cathrine S Notland, Robert Szulkin, et al.
European Urology Focus|March 23, 2022
Clinical Trial Protocol for ProBio: An Outcome-adaptive and Randomised Multiarm Biomarker-driven Study in Patients with Metastatic Prostate CancerBram De Laere, Alessio Crippa, Andrea Discacciati, et al.
Biomedical Engineering Online|November 29, 2024
Transcatheter bicuspid venous valve prostheses: fluid mechanical performance testing of artificial nonwoven leafletsAndreas Götz, Sabine Illner, Nicklas Fiedler, et al.
Biomolecules|January 8, 2025
XModNN: Explainable Modular Neural Network to Identify Clinical Parameters and Disease Biomarkers in Transcriptomic DatasetsJan Oldenburg, Jonas Wagner, Sascha Troschke-Meurer, et al.
Acta Oncologica (Stockholm, Sweden)|September 6, 2014
Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocolsTorgrim Tandstad, Arne Solberg, Ulf Håkansson, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Pharmacogenetics and Genomics|September 11, 2009
Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histologySigrid M Kraggerud, Jan Oldenburg, Grethe I Alnaes, et al.
Journal of Cancer Survivorship : Research and Practice|February 28, 2016
Aspects of posttraumatic stress disorder in long-term testicular cancer survivors: cross-sectional and longitudinal findingsAlv A Dahl, Marie Østby-Deglum, Jan Oldenburg, et al.
European Urology|September 4, 2012
Contemporary management of postchemotherapy testis cancerSiamak Daneshmand, Peter Albers, Sophie Dorothea Fosså, et al.
BMC Molecular and Cell Biology|June 3, 2021
Methodology for comprehensive cell-level analysis of wound healing experiments using deep learning in MATLABJan Oldenburg, Lisa Maletzki, Anne Strohbach, et al.
Oncotargets and Therapy|February 2, 2017
Overall survival in renal cell carcinoma after introduction of targeted therapies: a Norwegian population-based studyChristian Beisland, Tom B Johannesen, Olbjorn Klepp, et al.
Cancer Management and Research|January 28, 2025
Overall Survival of Patients with Metastatic Renal Cell Carcinoma Following the Introduction of Targeted and Immunotherapies: A Norwegian Retrospective, Real-World Registry Data Study (RECON3)Katarina Puco, Cathrine S Notland, Robert Szulkin, et al.
European Urology Focus|March 23, 2022
Clinical Trial Protocol for ProBio: An Outcome-adaptive and Randomised Multiarm Biomarker-driven Study in Patients with Metastatic Prostate CancerBram De Laere, Alessio Crippa, Andrea Discacciati, et al.
Biomedical Engineering Online|November 29, 2024
Transcatheter bicuspid venous valve prostheses: fluid mechanical performance testing of artificial nonwoven leafletsAndreas Götz, Sabine Illner, Nicklas Fiedler, et al.
Biomolecules|January 8, 2025
XModNN: Explainable Modular Neural Network to Identify Clinical Parameters and Disease Biomarkers in Transcriptomic DatasetsJan Oldenburg, Jonas Wagner, Sascha Troschke-Meurer, et al.
Acta Oncologica (Stockholm, Sweden)|September 6, 2014
Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocolsTorgrim Tandstad, Arne Solberg, Ulf Håkansson, et al.
Pageof 10